How to select and validate a generic CHO HCP ELISA for process development
Recorded
Wednesday, June 22, 2022 · 1:00 p.m.
ABOUT THIS WEBINAR
Sponsored by: Cytiva Off-the-shelf generic and commercial CHO HCP ELISAs are commonly used to quantitate HCP in early process development. However, it’s challenging to find and choose a generic ELISA suited to a process. Here we share a case study on selection criteria and validation of a generic ELISA for process development.
Learning Objectives: Gain access to practical guidance and an intuitive understanding of how to establish a generic CHO HCP ELISA for your process development. Learn how to compare generic ELISA kits in terms of specificity, sensitivity, reproducibility, robustness, coverage, and process compatibility.
Mohamed Shaker is a lead analytical development scientist for the Fast Trak™ team at Cytiva and is based in Marlborough, MA, USA. Mohamed has 13 years of biopharma experience spanning upstream (including perfusion and transfections), downstream...